{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:23:25Z","timestamp":1777044205061,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Vascular Surgery"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1053\/j.semvascsurg.2022.12.004","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T21:02:34Z","timestamp":1672174954000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Racial and ethnic disparities in clinical trials and peripheral artery disease"],"prefix":"10.1053","volume":"36","author":[{"given":"Alexander D.","family":"DiBartolomeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent L.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0001","unstructured":"Part II, 1938, Food, Drug, and Cosmetic Act. US Food and Drug Administration. Accessed January 5, 2023. https:\/\/www.fda.gov\/about-fda\/changes-science-law-and-regulatory-authorities\/part-ii-1938-food-drug-cosmetic-act."},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group","volume":"5","author":"Carson","year":"1999","journal-title":"J Card Fail"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0003","unstructured":"National Institutes of Health Revitalization Act of 1993: Act to Amend the Public Health Service Act to Revise and Extend the Progras of the National Institutes of Health, and for Other Purposes. Pub. L. No.103-43 (June 20, 1993)."},{"issue":"suppl 7","key":"10.1053\/j.semvascsurg.2022.12.004_bib0004","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/cncr.28575","article-title":"Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials","volume":"120","author":"Chen","year":"2014","journal-title":"Cancer"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/jwh.2012.3733","article-title":"Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials","volume":"21","author":"Coakley","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0006","unstructured":"Racial and Ethnic Diversity in the United States: 2010 Census and 2020 Census. US Census Bureau. Accessed August 12, 2021. https:\/\/www.census.gov\/library\/visualizations\/interactive\/racial-and-ethnic-diversity-in-the-united-states-2010-and-2020-census.html."},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0007","series-title":"The US will become \u201cminority white\u201d in 2045, Census projects","author":"Frey","year":"2022"},{"issue":"suppl 2","key":"10.1053\/j.semvascsurg.2022.12.004_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/00333549141291S203","article-title":"What are health disparities and health equity? We need to be clear","volume":"129","author":"Braveman","year":"2014","journal-title":"Public Health Rep"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0009","doi-asserted-by":"crossref","unstructured":"Peters U, Turner B, Alvarez D, et al. Considerations for embedding inclusive research principles in the design and execution of clinical trials [published online ahead of print October 14, 2022]. Ther Innov Regul Sci. doi:10.1007\/s43441-022-00464-3.","DOI":"10.1007\/s43441-022-00464-3"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0010","series-title":"National Institutes of Health Minority Health and Health Disparities Strategic Plan 2021-2025","year":"2022"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/clpt.2008.141","article-title":"The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies","volume":"84","author":"Yasuda","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0012","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0013","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/CIRCRESAHA.121.318243","article-title":"White Solaru KT. Racial and ethnic disparities in peripheral artery disease","volume":"128","author":"Hackler","year":"2021","journal-title":"Circ Res"},{"issue":"3","key":"10.1053\/j.semvascsurg.2022.12.004_bib0014","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1016\/j.jvs.2021.06.311","article-title":"Disparities of health care access among hispanics at risk of lower extremity amputation","volume":"74","author":"Tan","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.semvascsurg.2022.05.003","article-title":"Disparities in peripheral artery disease care: a review and call for action","volume":"35","author":"Demsas","year":"2022","journal-title":"Semin Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1538574407303679","article-title":"Race independently impacts outcome of infrapopliteal bypass for symptomatic arterial insufficiency","volume":"41","author":"Rowe","year":"2007","journal-title":"Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0017","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jvs.2007.07.021","article-title":"Disparities in the treatment and outcomes of vascular disease in Hispanic patients","volume":"46","author":"Morrissey","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0018","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jvs.2022.06.026","article-title":"Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia","volume":"76","author":"Anjorin","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0019","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/diacare.26.2.495","article-title":"Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans","volume":"26","author":"Young","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2105\/AJPH.2018.304369","article-title":"Disproportionate sterilization of Latinos under California's Eugenic Sterilization Program, 1920-1945","volume":"108","author":"Novak","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0021","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0021-9681(55)90153-3","article-title":"Untreated syphilis in the male Negro: background and current status of patients in the Tuskegee study","volume":"2","author":"Schuman","year":"1955","journal-title":"J Chronic Dis"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jme.19.1.28","article-title":"The medical ethics of the 'father of gynaecology', Dr J Marion Sims","volume":"19","author":"Ojanuga","year":"1993","journal-title":"J Med Ethics"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-genom-083115-022536","article-title":"Lessons from HeLa cells: the ethics and policy of biospecimens","volume":"17","author":"Beskow","year":"2016","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0024","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1353\/hpu.2006.0126","article-title":"The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research","volume":"17","author":"Katz","year":"2006","journal-title":"J Health Care Poor Underserved"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","article-title":"Increasing diversity in clinical trials: overcoming critical barriers","volume":"44","author":"Clark","year":"2019","journal-title":"Curr Probl Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0026","doi-asserted-by":"crossref","first-page":"429","DOI":"10.18865\/ed.30.3.429","article-title":"Impact of COVID-19 on clinical research and inclusion of diverse populations","volume":"3","author":"Lackland","year":"2020","journal-title":"Ethn Dis"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0027","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/jama.2018.13609","article-title":"Examining how race, ethnicity, and ancestry data are used in biomedical research","volume":"320","author":"Bonham","year":"2018","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0028","series-title":"Workshop on the Use of Race and Ethnicity in Genomics and Biomedical Research: Meeting Summary","year":"2022"},{"issue":"suppl","key":"10.1053\/j.semvascsurg.2022.12.004_bib0029","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making","volume":"51","author":"Bradbury","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0031","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jvs.2014.06.116","article-title":"Association of monocyte tumor necrosis factor \u03b1 expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease","volume":"61","author":"Pande","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0033","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0034","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1053\/j.semvascsurg.2022.12.004_bib0035","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/01.CIR.100.17.e75","article-title":"Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: clinical trial methodology. Basel PAD Clinical Trial Methodology Group","volume":"100","author":"Labs","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.semvascsurg.2022.12.004_bib0036","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0037","doi-asserted-by":"crossref","first-page":"j5085","DOI":"10.1136\/bmj.j5085","article-title":"CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials","volume":"359","author":"Welch","year":"2017","journal-title":"BMJ"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0038","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/107327481602300404","article-title":"Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer","volume":"23","author":"Hamel","year":"2016","journal-title":"Cancer Control"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0039","series-title":"Collection of Race and Ethnicity Data in Clinical Trials Guidance for Industry and Food and Drug Administration Staff","year":"2016"},{"key":"10.1053\/j.semvascsurg.2022.12.004_bib0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1525-1497.2006.00485.x","article-title":"Understanding African Americans' views of the trustworthiness of physicians","volume":"21","author":"Jacobs","year":"2006","journal-title":"J Gen Intern Med"}],"container-title":["Seminars in Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796722000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796722000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:39:24Z","timestamp":1760247564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895796722000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0895796722000849"],"URL":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2022.12.004","relation":{},"ISSN":["0895-7967"],"issn-type":[{"value":"0895-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic disparities in clinical trials and peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2022.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}